MRC1 and glioblastoma: Upregulated H3K9la activates LUC7L2 transcription, and LUC7L2 mediates the retention of MLH1 intron 7 to reduce MLH1 expression, inhibit MMR (mismatch repair) and ultimately promote TMZ resistance in GBM.73